Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease

被引:534
作者
Ellebrecht, Christoph T. [1 ]
Bhoj, Vijay G. [2 ]
Nace, Arben [1 ]
Choi, Eun Jung [1 ]
Mao, Xuming [1 ]
Cho, Michael Jeffrey [1 ]
Di Zenzo, Giovanni [3 ]
Lanzavecchia, Antonio [4 ]
Seykora, John T. [1 ]
Cotsarelis, George [1 ]
Milone, Michael C. [2 ]
Payne, Aimee S. [1 ]
机构
[1] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] IDI IRCCS, Mol & Cellular Biol Lab, I-00167 Rome, Italy
[4] Inst Biomed Res, CH-6500 Bellinzona, Switzerland
关键词
B-CELL; PEMPHIGUS-VULGARIS; PERSISTENCE; ACTIVATION; 4-1BB; DESMOGLEIN-3; MALIGNANCIES; SEGREGATION; INTERFACE; LYMPHOMA;
D O I
10.1126/science.aaf6756
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ideally, therapy for autoimmune diseases should eliminate pathogenic autoimmune cells while sparing protective immunity, but feasible strategies for such an approach have been elusive. Here, we show that in the antibody-mediated autoimmune disease pemphigus vulgaris (PV), autoantigen-based chimeric immunoreceptors can direct T cells to kill autoreactive B lymphocytes through the specificity of the B cell receptor (BCR). We engineered human T cells to express a chimeric autoantibody receptor (CAAR), consisting of the PV autoantigen, desmoglein (Dsg) 3, fused to CD137-CD3 zeta signaling domains. Dsg3 CAAR-T cells exhibit specific cytotoxicity against cells expressing anti-Dsg3 BCRs in vitro and expand, persist, and specifically eliminate Dsg3-specific B cells in vivo. CAAR-T cells may provide an effective and universal strategy for specific targeting of autoreactive B cells in antibody-mediated autoimmune disease.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 37 条
[1]   The molecular architecture of cadherins in native epidermal desmosomes [J].
Al-Amoudi, Ashraf ;
Diez, Daniel Castano ;
Betts, Matthew J. ;
Frangakis, Achilleas S. .
NATURE, 2007, 450 (7171) :832-U8
[2]   Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias [J].
Brentjens, Renier J. ;
Riviere, Isabelle ;
Park, Jae H. ;
Davila, Marco L. ;
Wang, Xiuyan ;
Stefanski, Jolanta ;
Taylor, Clare ;
Yeh, Raymond ;
Bartido, Shirley ;
Borquez-Ojeda, Oriana ;
Olszewska, Malgorzata ;
Bernal, Yvette ;
Pegram, Hollie ;
Przybylowski, Mark ;
Hollyman, Daniel ;
Usachenko, Yelena ;
Pirraglia, Domenick ;
Hosey, James ;
Santos, Elmer ;
Halton, Elizabeth ;
Maslak, Peter ;
Scheinberg, David ;
Jurcic, Joseph ;
Heaney, Mark ;
Heller, Glenn ;
Frattini, Mark ;
Sadelain, Michel .
BLOOD, 2011, 118 (18) :4817-4828
[3]   Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients [J].
Cho, Michael Jeffrey ;
Lo, Agnes S. Y. ;
Mao, Xuming ;
Nagler, Arielle R. ;
Ellebrecht, Christoph T. ;
Mukherjee, Eric M. ;
Hammers, Christoph M. ;
Choi, Eun-Jung ;
Sharma, Preety M. ;
Uduman, Mohamed ;
Li, Hong ;
Rux, Ann H. ;
Farber, Sara A. ;
Rubin, Courtney B. ;
Kleinstein, Steven H. ;
Sachais, Bruce S. ;
Posner, Marshall R. ;
Cavacini, Lisa A. ;
Payne, Aimee S. .
NATURE COMMUNICATIONS, 2014, 5
[4]   T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand [J].
Choudhuri, K ;
Wiseman, D ;
Brown, MH ;
Gould, K ;
van der Merwe, PA .
NATURE, 2005, 436 (7050) :578-582
[5]   Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response [J].
Colliou, Natacha ;
Picard, Damien ;
Caillot, Frederique ;
Calbo, Sebastien ;
Le Corre, Stephanie ;
Lim, Annick ;
Lemercier, Brigitte ;
Le Mauff, Brigitte ;
Maho-Vaillant, Maud ;
Jacquot, Serge ;
Bedane, Christophe ;
Bernard, Philippe ;
Caux, Frederic ;
Prost, Catherine ;
Delaporte, Emmanuel ;
Doutre, Marie-Sylvie ;
Dreno, Brigitte ;
Franck, Nathalie ;
Ingen-Housz-Oro, Saskia ;
Chosidow, Olivier ;
Pauwels, Christine ;
Picard, Catherine ;
Roujeau, Jean-Claude ;
Sigal, Michele ;
Tancrede-Bohin, Emmanuelle ;
Templier, Isabelle ;
Eming, Ruediger ;
Hertl, Michael ;
D'Incan, Michel ;
Joly, Pascal ;
Musette, Philippe .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (175)
[6]   Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study [J].
Cruz, Conrad Russell Y. ;
Micklethwaite, Kenneth P. ;
Savoldo, Barbara ;
Ramos, Carlos A. ;
Lam, Sharon ;
Ku, Stephanie ;
Diouf, Oumar ;
Liu, Enli ;
Barrett, A. John ;
Ito, Sawa ;
Shpall, Elizabeth J. ;
Krance, Robert A. ;
Kamble, Rammurti T. ;
Carrum, George ;
Hosing, Chitra M. ;
Gee, Adrian P. ;
Mei, Zhuyong ;
Grilley, Bambi J. ;
Heslop, Helen E. ;
Rooney, Cliona M. ;
Brenner, Malcolm K. ;
Bollard, Catherine M. ;
Dotti, Gianpietro .
BLOOD, 2013, 122 (17) :2965-2973
[7]   Mucosal Pemphigus Vulgaris Anti-Dsg3 IgG Is Pathogenic to the Oral Mucosa of Humanized Dsg3 Mice [J].
Culton, Donna A. ;
McCray, Suzanne K. ;
Park, Moonhee ;
Roberts, James C. ;
Li, Ning ;
Zedek, Daniel C. ;
Anhalt, Grant J. ;
Cowley, Dale O. ;
Liu, Zhi ;
Diaz, Luis A. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (06) :1590-1597
[8]   Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia [J].
Davila, Marco L. ;
Riviere, Isabelle ;
Wang, Xiuyan ;
Bartido, Shirley ;
Park, Jae ;
Curran, Kevin ;
Chung, Stephen S. ;
Stefanski, Jolanta ;
Borquez-Ojeda, Oriana ;
Olszewska, Malgorzata ;
Qu, Jinrong ;
Wasielewska, Teresa ;
He, Qing ;
Fink, Mitsu ;
Shinglot, Himaly ;
Youssif, Maher ;
Satter, Mark ;
Wang, Yongzeng ;
Hosey, James ;
Quintanilla, Hilda ;
Halton, Elizabeth ;
Bernal, Yvette ;
Bouhassira, Diana C. G. ;
Arcila, Maria E. ;
Gonen, Mithat ;
Roboz, Gail J. ;
Maslak, Peter ;
Douer, Dan ;
Frattini, Mark G. ;
Giralt, Sergio ;
Sadelain, Michel ;
Brentjens, Renier .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)
[9]   The kinetic-segregation model: TCR triggering and beyond [J].
Davis, Simon J. ;
van der Merwe, P. Anton .
NATURE IMMUNOLOGY, 2006, 7 (08) :803-809
[10]   Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface [J].
Di Zenzo, Giovanni ;
Di Lullo, Giulia ;
Corti, Davide ;
Calabresi, Valentina ;
Sinistro, Anna ;
Vanzetta, Fabrizia ;
Didona, Biagio ;
Cianchini, Giuseppe ;
Hertl, Michael ;
Eming, Rudiger ;
Amagai, Masayuki ;
Ohyama, Bungo ;
Hashimoto, Takashi ;
Sloostra, Jerry ;
Sallusto, Federica ;
Zambruno, Giovanna ;
Lanzavecchia, Antonio .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (10) :3781-3790